Esomeprazole Magnesium Patent Expiration
Esomeprazole Magnesium was first introduced by Astrazeneca Pharmaceuticals Lp
Esomeprazole Magnesium Patents
Given below is the list of patents protecting Esomeprazole Magnesium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Esomeprazole Magnesium | US10076494 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
Esomeprazole Magnesium | US10835488 | Stable orally disintegrating pharmaceutical compositions | Dec 08, 2036 | Dexcel |
Nexium |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca |
Nexium 24hr |
US6428810 (Pediatric) | Pharmaceutical formulation comprising omeprazole |
May 03, 2020
(Expired) | Astrazeneca Lp |
Nexium | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca |
Nexium 24hr | US6428810 | Pharmaceutical formulation comprising omeprazole |
Nov 03, 2019
(Expired) | Astrazeneca Lp |
Nexium |
US6147103 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
Nexium |
US6166213 (Pediatric) | Omeprazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
Nexium |
US6191148 (Pediatric) | Omerazole process and compositions thereof |
Apr 09, 2019
(Expired) | Astrazeneca |
Nexium |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
Nexium |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
Nexium |
US8466175 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca |
Nexium 24hr |
US6369085 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 25, 2018
(Expired) | Astrazeneca Lp |
Nexium 24hr |
US7411070 (Pediatric) | Form of S-omeprazole |
Nov 18, 2018
(Expired) | Astrazeneca Lp |
Nexium | US6147103 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
Nexium | US6166213 | Omeprazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
Nexium | US6191148 | Omerazole process and compositions thereof |
Oct 09, 2018
(Expired) | Astrazeneca |
Nexium | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
Nexium | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
Nexium | US8466175 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca |
Nexium 24hr | US6369085 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
Nexium 24hr | US7411070 | Form of S-omeprazole |
May 25, 2018
(Expired) | Astrazeneca Lp |
Nexium 24hr | US7411070 | Form of S-omeprazole |
May 18, 2018
(Expired) | Astrazeneca Lp |
Nexium |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca |
Nexium 24hr |
US5900424 (Pediatric) | Omeprazole magnesium salt form |
Nov 04, 2016
(Expired) | Astrazeneca Lp |
Nexium | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca |
Nexium 24hr | US5900424 | Omeprazole magnesium salt form |
May 04, 2016
(Expired) | Astrazeneca Lp |
Nexium |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca |
Nexium 24hr |
US5714504 (Pediatric) | Compositions |
Aug 03, 2015
(Expired) | Astrazeneca Lp |
Nexium |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca |
Nexium 24hr |
US5690960 (Pediatric) | Pharmaceutical formulation of omeprazole |
May 25, 2015
(Expired) | Astrazeneca Lp |
Nexium | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca |
Nexium 24hr | US5714504 | Compositions |
Feb 03, 2015
(Expired) | Astrazeneca Lp |
Nexium |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca |
Nexium |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca |
Nexium 24hr |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
Nexium 24hr |
US6875872 (Pediatric) | Compounds |
Nov 27, 2014
(Expired) | Astrazeneca Lp |
Nexium | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca |
Nexium 24hr | US5690960 | Pharmaceutical formulation of omeprazole |
Nov 25, 2014
(Expired) | Astrazeneca Lp |
Nexium | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca |
Nexium | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca |
Nexium 24hr | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca Lp |
Nexium 24hr | US6875872 | Compounds |
May 27, 2014
(Expired) | Astrazeneca Lp |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Esomeprazole Magnesium's patents.
Latest Legal Activities on Esomeprazole Magnesium's Patents
Given below is the list recent legal activities going on the following patents of Esomeprazole Magnesium.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
Recordation of Patent Grant Mailed Critical
| 17 Nov, 2020 | US10835488 |
Patent Issue Date Used in PTA Calculation Critical
| 17 Nov, 2020 | US10835488 |
Email Notification Critical
| 29 Oct, 2020 | US10835488 |
Issue Notification Mailed Critical
| 28 Oct, 2020 | US10835488 |
Email Notification Critical
| 13 Oct, 2020 | US10835488 |
Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
Dispatch to FDC | 10 Oct, 2020 | US10835488 |
Corrected Notice of Allowability | 07 Oct, 2020 | US10835488 |
Esomeprazole Magnesium's Family Patents
